GlassScriptPhysician profile
Hyung Kim
NPI 1891792693
$10,088.16
in general payments reported to CMS, 2019-2025
12 companies · $56.14 in 2025
The $56.14 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2021: $237 · 2022: $303 · 2023: $4,713 · 2024: $4,599 · 2025: $56.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Food and Beverage: $1,368 · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Food and Beverage | $1,367.60 |
| Education | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $8,754.37 | 2022-2024 | |
| Intuitive Surgical, INC. | $650.00 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $206.53 | 2023-2025 | Belbuca, Xtampza |
| Aveo Pharmaceuticals, INC. | $167.97 | 2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Boston Scientific Corporation | $81.72 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $41.85 | 2023 | Erleada |
| Astrazeneca Pharmaceuticals LP | $31.00 | 2019 | |
| Janssen Biotech, INC. | $20.28 | 2024 | Erleada, Balversa |
| Medtronic, INC. | $18.75 | 2021 | |
| Becton, Dickinson and Company | $15.69 | 2023 | Bard Urinary Drainage Bag |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.